UnratedDrug recall · FDA · Published December 18, 2017
Osmotica Methylphenidate Tablets Recall: Subpotent Drug Risk
Osmotica Pharmaceutical Corp recalls 27mg methylphenidate tablets due to subpotent drug levels. Affected products have NDC 13811-707-10 and lot 170027A. No remedy specified in recall notice.
📍Recalling firmOsmotica Pharmaceutical Corp895 Sawyer Rd · Marietta, GA 30062-2257
✎ GovInfoNow plain-language explainer
Osmotica Pharmaceutical Corp is recalling 27mg methylphenidate hydrochloride extended-release tablets that may contain less active ingredient than labeled. This could lead to inadequate treatment for ADHD or other conditions requiring the medication. Read more at govinfonow.com/recall/41010-osmotica-methylphenidate-tablets-recall-subpotent-drug-risk.
“Osmotica Methylphenidate Tablets Recall: Subpotent Drug Risk.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/41010-osmotica-methylphenidate-tablets-recall-subpotent-drug-risk. Based on FDA recall #D-0110-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0110-2018%22&limit=1).
Osmotica Pharmaceutical Corp recalled Methylphenidate Hydrochloride Extended-release Tablets, USP 27 mg, 100-count bottles from Trigen Laboratories due to subpotent drug risks, the FDA said on Dec. 18, 2017.
The recall involves subpotent drug risks associated with the affected Methylphenidate Hydrochloride Extended-release Tablets, USP 27 mg.
Context
GovInfoNow's records show Osmotica Pharmaceutical Corp has issued two other recalls since Sept. 16, 2013, including a Feb. 28, 2018 recall of Methylphenidate Tablets 36mg for subpotent drug risk and a Sept. 16, 2013 recall of Venlafaxine 225mg due to dissolution failure. Other recent recalls of similar products include Unichem busPIRone 5mg Tablets Recall (April 13, 2026), Major Pharmaceuticals Levothyroxine Tablets Recall (July 13, 2026), and Macleods Levothyroxine Tablets Recall (Feb. 26, 2026).
How to tell if you have this one
Check for NDC code 13811-707-10 and lot number 170027A on the product label. These tablets are prescription-only and sold by Trigen Laboratories in Bridgewater, NJ.
Brand
Osmot: Trigen Laboratories
Category
Drug
FDA recall event · 2 products
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0110-2018 (December 18, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0110-2018 to see it in context.
Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.